Fragasso Financial Advisors Inc Buys 20 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fragasso Financial Advisors Inc raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.0% during the fourth quarter, HoldingsChannel reports. The fund owned 687 shares of the medical equipment provider’s stock after acquiring an additional 20 shares during the quarter. Fragasso Financial Advisors Inc’s holdings in Intuitive Surgical were worth $359,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in the company. Hazlett Burt & Watson Inc. grew its holdings in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after purchasing an additional 20 shares during the last quarter. Mitchell Mcleod Pugh & Williams Inc. grew its stake in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after buying an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC raised its holdings in shares of Intuitive Surgical by 1.6% in the third quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after buying an additional 21 shares during the period. Meeder Advisory Services Inc. boosted its holdings in Intuitive Surgical by 0.3% during the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock valued at $3,629,000 after acquiring an additional 22 shares during the period. Finally, Falcon Wealth Planning grew its position in Intuitive Surgical by 0.4% in the 3rd quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock valued at $2,797,000 after acquiring an additional 23 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 1.4 %

Shares of ISRG opened at $539.75 on Tuesday. The company has a 50 day moving average of $536.58 and a two-hundred day moving average of $495.83. The company has a market cap of $192.25 billion, a price-to-earnings ratio of 86.78, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a twelve month low of $355.17 and a twelve month high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. On average, sell-side analysts expect that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

Insider Activity

In other news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares of the company’s stock, valued at approximately $3,638,990. This represents a 26.54 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Mark Brosius sold 2,128 shares of Intuitive Surgical stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares of the company’s stock, valued at $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 48,190 shares of company stock worth $25,012,927 over the last 90 days. 0.90% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

ISRG has been the subject of several research analyst reports. BTIG Research lifted their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Raymond James lifted their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Leerink Partners upped their target price on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Morgan Stanley raised shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.